Forms four expert panels to draft permission guidelines

Following more than 2,200 deaths in clinical trials in the past five years, the government has finally set up four expert committees to streamline approvals and evolve standard operating procedures for marketing of drugs in India, which are discovered abroad. The move comes following Supreme Court's observation that the Ministry of Health was watching meekly as the unregulated clinical trial sector played "havoc" with the people.